These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


483 related items for PubMed ID: 11527248

  • 1. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma.
    Amayasu H, Nakabayashi M, Akahori K, Ishizaki Y, Shoji T, Nakagawa H, Hasegawa H, Yoshida S.
    Ann Allergy Asthma Immunol; 2001 Aug; 87(2):146-50. PubMed ID: 11527248
    [Abstract] [Full Text] [Related]

  • 2. Clarithromycin suppresses bronchial hyperresponsiveness associated with eosinophilic inflammation in patients with asthma.
    Amayasu H, Yoshida S, Ebana S, Yamamoto Y, Nishikawa T, Shoji T, Nakagawa H, Hasegawa H, Nakabayashi M, Ishizaki Y.
    Ann Allergy Asthma Immunol; 2000 Jun; 84(6):594-8. PubMed ID: 10875487
    [Abstract] [Full Text] [Related]

  • 3. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma.
    Yoshida S, Amayasu H, Sakamoto H, Onuma K, Shoji T, Nakagawa H, Tajima T.
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):171-6. PubMed ID: 9494450
    [Abstract] [Full Text] [Related]

  • 4. Anti-inflammatory effect of roxithromycin in patients with aspirin-intolerant asthma.
    Shoji T, Yoshida S, Sakamoto H, Hasegawa H, Nakagawa H, Amayasu H.
    Clin Exp Allergy; 1999 Jul; 29(7):950-6. PubMed ID: 10383596
    [Abstract] [Full Text] [Related]

  • 5. Bronchial hyperresponsiveness, hypersensitivity to analgesics and urinary leukotriene E4 excretion in patients with aspirin-intolerant asthma.
    Yoshida S, Nakagawa H, Yamawaki Y, Sakamoto H, Akahori K, Nakabayashi M, Sakamoto M, Hasegawa H, Shoji T, Tajimab T, Amayasu H.
    Int Arch Allergy Immunol; 1998 Oct; 117(2):146-51. PubMed ID: 9784659
    [Abstract] [Full Text] [Related]

  • 6. Relationship between induced sputum cell counts and fluid-phase eosinophil cationic protein and clinical or physiologic profiles in mild asthma.
    Gutiérrez V, Prieto L, Torres V, Trenor R, Pérez C, Bertó JM, Marín J.
    Ann Allergy Asthma Immunol; 1999 Jun; 82(6):559-65. PubMed ID: 10400484
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Correlation between airway hyperresponsiveness and airway inflammation in a young adult population: eosinophil, ECP, and cytokine levels in induced sputum.
    Obase Y, Shimoda T, Mitsuta K, Matsuo N, Matsuse H, Kohno S.
    Ann Allergy Asthma Immunol; 2001 Mar; 86(3):304-10. PubMed ID: 11289329
    [Abstract] [Full Text] [Related]

  • 10. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
    Lönnkvist K, Hellman C, Lundahl J, Halldén G, Hedlin G.
    J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
    [Abstract] [Full Text] [Related]

  • 11. Effect of pranlukast on bronchial inflammation in patients with asthma.
    Yoshida S, Ishizaki Y, Shoji T, Onuma K, Nakagawa H, Nakabayashi M, Akahori K, Hasegawa H, Amayasu H.
    Clin Exp Allergy; 2000 Jul; 30(7):1008-14. PubMed ID: 10848924
    [Abstract] [Full Text] [Related]

  • 12. [The effect of salmeterol on the number of hypodense eosinophils, eosinophilic cationic protein levels ECP in serum, bronchial hyperresponsiveness and lung function test in patients with bronchial asthma].
    Chazan R, Grubek-Jaworska H, Hermanowicz-Salomon J, Droszcz W.
    Pol Merkur Lekarski; 1997 Oct; 3(16):180-2. PubMed ID: 9461726
    [Abstract] [Full Text] [Related]

  • 13. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
    Taylor DA, Jensen MW, Kanabar V, Engelstätter R, Steinijans VW, Barnes PJ, O'Connor BJ.
    Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
    [Abstract] [Full Text] [Related]

  • 14. Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine.
    Yoo Y, Koh YY, Kang H, Yu J, Nah KM, Kim CK.
    Allergy; 2004 Oct; 59(10):1055-62. PubMed ID: 15355463
    [Abstract] [Full Text] [Related]

  • 15. Salmeterol decreases eosinophilic cationic protein and rescue medication in patients inhaling beclomethasone dipropionate: preliminary study in mild and moderate asthma in Trinidad, West Indies.
    Pinto Pereira LM, Clement Y, Rouse J, Matthew J, Asgarali Z, Ramoutar D, Teelucksingh S.
    Int J Clin Pharmacol Res; 2003 Oct; 23(2-3):69-74. PubMed ID: 15025036
    [Abstract] [Full Text] [Related]

  • 16. [Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA)].
    Imokawa S, Sato A, Taniguchi M, Toyoshima M, Nakazawa K, Hayakawa H, Chida K.
    Arerugi; 1992 Oct; 41(10):1515-20. PubMed ID: 1482300
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
    Yoshida S, Sakamoto H, Ishizaki Y, Onuma K, Shoji T, Nakagawa H, Hasegawa H, Nakabayashi M, Amayasu H.
    Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
    [Abstract] [Full Text] [Related]

  • 18. Induced sputum to assess airway inflammation: a study of reproducibility.
    Spanevello A, Migliori GB, Sharara A, Ballardini L, Bridge P, Pisati P, Neri M, Ind PW.
    Clin Exp Allergy; 1997 Oct; 27(10):1138-44. PubMed ID: 9383253
    [Abstract] [Full Text] [Related]

  • 19. Safety and application of induced sputum analysis in childhood asthma.
    Covar RA, Spahn JD, Martin RJ, Silkoff PE, Sundstrom DA, Murphy J, Szefler SJ.
    J Allergy Clin Immunol; 2004 Sep; 114(3):575-82. PubMed ID: 15356559
    [Abstract] [Full Text] [Related]

  • 20. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
    Ohbayashi H.
    Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 25.